Crinetics Pharmaceuticals Lands $40,000,000 Series A Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0bdba431-d315-4cbc-bdaa-cbf1935ae156
Date
11/3/2015
Company Name
Crinetics Pharmaceuticals
Mailing Address
6197 Cornerstone Court San Diego, CA 92121 USA
Company Description
Crinetics Pharmaceuticals discovers and develops important new drugs for endocrinologists and their patients. Our internal discovery programs target peptide hormone receptors for the treatment of specialty endocrine disorders in the areas of neuroendocrinology, reproductive medicine, and women’s health.
Website
http://www.crinetics.com
Transaction Type
Venture Equity
Transaction Amount
$40,000,000
Transaction Round
Series A
Proceeds Purposes
Crinetics plans to use the proceeds to advance development of its small molecule somatostatin agonist program to clinical proof-of-concept for the treatment of acromegaly, as well as to move additional programs into development.
M&A Terms
Venture Investor
5AM Ventures
Venture Investor
Versant Ventures
Venture Investor
Vivo Capital